featured
Angiographic Biomarkers Significantly Predict Treatment Response to Intravitreal Aflibercept in Patients With Diabetic Macular Edema
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Scientific Reports
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Angiographic biomarkers are significant predictors of treatment response to intravitreal aflibercept in diabetic macular edema
Sci Rep 2023 May 19;13(1)8128, M Hein, A Vukmirovic, IJ Constable, V Raja, A Athwal, KB Freund, C BalaratnasingamFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.